BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Teich N, Grümmer H, Jörgensen E, Liceni T, Holtkamp-Endemann F, Fischer T, Hohenberger S. Golimumab in real-world practice in patients with ulcerative colitis: Twelve-month results. World J Gastroenterol 2020; 26(21): 2852-2863 [PMID: 32550760 DOI: 10.3748/wjg.v26.i21.2852]
URL: https://www.wjgnet.com/1007-9327/full/v26/i21/2852.htm
Number Citing Articles
1
Niels Teich, Harald Grümmer, Eric Jörgensen, Thomas Liceni, Frank Holtkamp-Endemann, Tim Fischer, Susanne Hohenberger. Golimumab improves work productivity in patients suffering from moderate to severe ulcerative colitis: results of a prospective study over 24 monthsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01747-z
2
Marc Ferrante, Anja Schirbel, Marieke J. Pierik, Thomas Haas, Mathurin Flamant, Ahmed Khalifa, George Philip, Freddy Cornillie, Alan G. Meehan, Marinella Govoni. Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational studyEuropean Journal of Gastroenterology & Hepatology 2022; 34(6): 646 doi: 10.1097/MEG.0000000000002374
3
Anthia Gatopoulou, Dimitrios K. Christodoulou, Konstantinos H. Katsanos, Dimitrios Bakos, Ioannis Mouzas, Maria Tzouvala, Angeliki Theodoropoulou, Gregorios Paspatis, George Theocharis, Konstantinos Thomopoulos, Olga Giouleme, Anastasia Kourikou, Spilios Manolakopoulos, Evanthia Zampeli, Spyros Michopoulos, Pantelis Karatzas, Marios Katsaros, Dimitris Moschovis, Eleni Orfanoudaki, Achilleas Livieratos, Evangelia Petrikkou, Gerassimos J. Mantzaris. Effect of golimumab on health-related quality of life, other patient-reported outcomes and healthcare resource utilization in patients with moderate-to-severe ulcerative colitis: a real-world multicenter, noninterventional, observational study in GreeceEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e615 doi: 10.1097/MEG.0000000000002182